Group One Trading’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,921
| Closed | -$342K | – | 8152 |
|
|
2023
Q4 | $342K | Buy |
1,921
+1,857
| +2,902% | +$914K | ﹤0.01% | 3386 |
|
|
2023
Q3 | $45.6K | Buy |
64
+38
| +146% | +$163K | ﹤0.01% | 5188 |
|
|
2023
Q2 | $120K | Buy |
26
+2
| +8% | +$6.94K | ﹤0.01% | 4436 |
|
|
2023
Q1 | $62.6K | Sell |
24
-85
| -78% | -$249K | ﹤0.01% | 4685 |
|
|
2022
Q4 | $284K | Buy |
109
+42
| +63% | +$146K | ﹤0.01% | 3542 |
|
|
2022
Q3 | $264K | Buy |
67
+8
| +14% | +$31.5K | ﹤0.01% | 3881 |
|
|
2022
Q2 | $154K | Buy |
59
+6
| +11% | +$15.6K | ﹤0.01% | 4553 |
|
|
2022
Q1 | $171K | Sell |
53
-4
| -7% | -$17.2K | ﹤0.01% | 4970 |
|
|
2021
Q4 | $355K | Sell |
57
-38
| -40% | -$292K | ﹤0.01% | 4500 |
|
|
2021
Q3 | $881K | Buy |
95
+45
| +90% | +$387K | ﹤0.01% | 3555 |
|
|
2021
Q2 | $509K | Buy |
50
+34
| +213% | +$559K | ﹤0.01% | 4206 |
|
|
2021
Q1 | $298K | Buy |
+16
| New | +$187K | ﹤0.01% | 4588 |
|
|
2016
Q3 | – | Hold |
0
| – | -$16K | – | 4994 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3905 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3405 |
|
|
2015
Q3 | – | Hold |
0
| – | -$164K | – | 5271 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2683 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2495 |
|
|
2014
Q4 | – | Hold |
0
| – | -$56K | – | 5356 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 3438 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 2318 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3211 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3922 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3593 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 2201 |
|
Other funds holding SEEL
Group One Trading's SEEL Position: Q4 2024 in Review
Group One Trading sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2024, closing a stake of 12 shares — an estimated $45 sold.
Group One Trading first reported a position in SEEL in Q2 2021 and held it in 13 quarters. The position peaked at $2.23M in Q3 2022. 2 funds tracked by Wall St. Rank hold SEEL as of Q4 2024.
- Group One Trading reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Group One Trading sold 12 Seelos Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $45.
- Group One Trading first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
- Group One Trading's Seelos Therapeutics, Inc. Common Stock position peaked at $2.23M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2024.
Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.